Skip to main content

Table 2 Pituitary hormone function at baseline in the study population (n = 101) and association with different parameters

From: Post-operative volumes following endoscopic surgery for non-functioning pituitary macroadenomas are predictive of further intervention, but not endocrine outcomes

Number of pituitary hormone deficiencies (at baseline) Gender p-value
Males (n = 62) Females (n = 39)
 • 0 12 (19.4%) 12 (41.6%) 0.06
 • 1–2 24 (38.7%) 17 (43.5%)
 • ≥3 26 (41.9%) 10 (25.6%)
Individual hormone axis
 • GH deficiency 43 (63.4%) 17 (43.5%) 0.01*
 • LH/FSH deficiency 37 (59.7%) 18 (21.2%) 0.22
 • ACTH deficiency 22 (35.3%) 11 (28.2%) 0.52
 • TSH deficiency 24 (38.7%) 12 (30.8%) 0.52
Number of pituitary hormone deficiencies (at baseline) Age at Surgery (mean ± SD)/ years p-value
 • 0 54.7 ± 13.0 0.001*
 • 1–2 57.7 ± 12.0
 • ≥3 63.8 ± 11.6
Individual hormone axis Age at Surgery (mean ± SD)/ years p-value
 • GH deficiency 60.6 ± 11.6 0.16
 • LH/FSH deficiency 63.5 ± 11.0 < 0.01*
 • ACTH deficiency 63.2 ± 13.2 0.03*
 • TSH deficiency 62.2 ± 12.0 0.06
  1. *p < 0.05 is statistically significant